publication venue for
- Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs. 599:217108-217108. 2024
- TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer. 533:215607-215607. 2022
- YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer. 500:51-63. 2021
- Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer. 492:84-95. 2020
- Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines. 433:18-32. 2018
- Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer. 426:4-13. 2018
- PKM2 contributes to cancer metabolism. 356:184-191. 2015
- Medulloblastoma stem cells: Modeling tumor heterogeneity. 338:23-31. 2013
- Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition. 248:165-174. 2007
- Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression. 224:53-65. 2005
- DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistance. 90:139-148. 1995
- Controlled delivery of taxol from microspheres composed of a blend of ethylene-vinyl acetate copolymer and poly (d,l-lactic acid). 88:73-79. 1995